Results 171 to 180 of about 614,692 (224)

Enabling laboratory readiness and preparedness for the evaluation of suspected viral hemorrhagic fevers: development of a laboratory toolkit. [PDF]

Infect Control Hosp Epidemiol
Turbett SE, Lazarus JE, Nardini MA, Braidt JE, Lane SA, Searle EF, Biddinger PD, Shenoy ES.   +7 more
europepmc   +1 more source

Viral hemorrhagic fevers (continued) (Week 44) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending November 5, 2022

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Can landscape management provide disease regulation services? A case study of Brazilian spotted fever incidence

Journal of Applied Ecology, Volume 63, Issue 10, October 2026.
Policy implications. Our results can help prioritize surveillance strategies and the implementation of preventive measures, particularly in areas where landscape structures cannot provide disease regulation services. Landscape management actions aimed at increasing the amount of forest areas in a more aggregated manner could help restore those ...
Nicolas Conserva, Paula Ribeiro Prist, Gabriela Farias Asmus, Niko Speybroeck, Leandro Reverberi‐Tambosi   +4 more
wiley   +1 more source

Viral hemorrhagic fevers:(Week 4) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending January 25, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 4, October 2026.
Increasing evidence indicates an association between type 2 diabetes mellitus and Alzheimer’s disease, contributing to the proposed concept of AD as “type 3 diabetes.” Shared biological features such as impaired insulin signaling, chronic inflammation, mitochondrial dysfunction, and oxidative stress have been observed in both T2DM and AD.
Deniz Catakli, Ozlem Ozen‐Basoglu, Ebru Busra Tuncgovde, Gonen Ozsarlak‐Sozer   +3 more
wiley   +1 more source

Phase IIB, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID‐19

European Journal of Haematology, Volume 117, Issue 4, Page 922-935, October 2026.
ABSTRACT Introduction Endothelial dysfunction is key in COVID‐19 pathogenesis. This randomized, double‐blind phase IIb trial investigated continuous intravenous infusion of defibrotide in patients hospitalized with SARS‐CoV‐2 infection and respiratory failure.
Ruben Jara Rubio, Antonio José Martinez‐Mellado, Jonathan Kiwitt‐Cárdenas, José G. Clavel, Bartolomé García‐Perez, Pedro Castro, Maribel Diaz‐Ricart, Andrés Carrillo‐Alcaraz, Amparo López‐Bernús, Enrique Bernal Morell, Aychel Roura, Sonia Marín, Francisco‐José Ruiz‐López, Elena Solana‐Martinez, Domingo Martinez‐Baño, Carlos L. Albacete Moreno, Enriqueta Andreu Soler, Adrián Tellez Santoyo, Sara Fernández Méndez, Jose A. Noguera Velasco, Iria Cebreiros Lopez, Andrés Parrilla, Alberto Espuny‐Miró, David García‐Bernal, Miguel Blanquer, Andrés Sánchez‐Salinas, Francisca Iniesta, Cristina Hernandez Garcia, Manuel Muro, Alfredo Minguela Puras, Antonio Moreno‐Docón, Alberto M. Torres‐Cantero, Maria Munoz Garcia, Manuel Serrano, Massimo Iacobelli, Carmelo Carlo‐Stella, Lee‐Jen Wei, Paul G. Richardson, José M. Moraleda   +38 more
wiley   +1 more source

Diagnosis and Management of Infectious Encephalitis in Adults: Guidelines From the European Academy of Neurology and European Society of Clinical Microbiology and Infectious Diseases

European Journal of Neurology, Volume 33, Issue 10, October 2026.
ABSTRACT Background Encephalitis is difficult to diagnose and manage, posing a challenge to clinicians. Since the last European guidelines were published in 2010, novel causes have emerged, diagnostic processes have evolved and treatments assessed which need to be reflected in updated guidelines.
Julia Granerod, Johann Sellner, Jean‐Paul Stahl, Sylviane Defres, Alexandra Mailles, Erich Schmutzhard, Elisabeth Aurelius, Thomas Whitfield, Luca Massacesi, Maarten J. Titulaer, Pille Taba, Benedict D. Michael, Tehmina Bharucha, Lance Turtle, Brendan Sargent, Arina Tamborska, Jonathan Cattrall, Yun Huang, Eva Maria Hodel, Suzannah Lant, Glynn Webb, Rajish S. K. Shil, Shalley Dhar, Diederik van de Beek, Marie Studahl, Matthijs C. Brouwer, Uta Meyding‐Lamade, Ava Easton, Bhagteshwar Singh, Tom Solomon   +29 more
wiley   +1 more source

Viral hemorrhagic fevers:(Week 15) Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending April 11, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Vaccines for viral hemorrhagic fevers--progress and shortcomings. [PDF]

Curr Opin Virol, 2013
Falzarano D, Feldmann H.
europepmc   +1 more source

Viral hemorrhagic fevers (Week 05) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents weeks ending February 1, 2020

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core